NCI medNews

"Non-Hodgkin's lymphoma during pregnancy" is redistributed by University of Bonn, Medical Center

Non-Hodgkin's lymphoma during pregnancy

208/06459

Get this document via a secure connection


Disease Description


CancerMail from the National Cancer Institute


###########################################################################


!!! ATTENTION !!!

The National Cancer Institute (NCI) has updated its cancer information delivery services. In the future, please use the Cancer.gov web site (Http: //cancer.gov/) to meet your cancer information needs. CancerMail users in the United States can obtain cancer information by telephone at 1-800-4-CANCER (1-800-422-6237).

The NCI will no longer support CancerMail after November 2002. If you have comments about the NCI's cancer information delivery services, contact us by e-mail at cancer.govstaff@mail.nih.gov or call 301-496-9096.

###########################################################################


This information is intended mainly for use by doctors and other health care professionals. If you have questions about this topic, you can ask your doctor, or call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

Information from PDQ -- for Health Professionals


DISEASE DESCRIPTION

Note: A separate PDQ summary on Adult Non-Hodgkin's Lymphoma Treatment is also available.

Since non-Hodgkin's lymphomas (NHL) occur in an older patient population than Hodgkin's disease, this may account for fewer reports of NHL patients with coexisting pregnancy.[1] Magnetic resonance imaging is the preferred tool for staging evaluation to avoid exposure to ionizing radiation.[2] Most of these lymphomas are aggressive and delay of therapy until after delivery appears to have poor outcomes according to anecdotal case series.[1,3-5] Consequently, some investigators favor immediate therapy, even during pregnancy.[5] Children exposed to high-dose doxorubicin-containing combination chemotherapy in utero (especially during the second and third trimester) have been found to be normal subsequently, with follow-up ranging from several months to 11 years.[5-8] There are no data regarding long-term effects on children exposed in utero for most of the chemotherapeutic agents used for treatment of NHL. Termination of pregnancy in the first trimester may be an option to allow therapy for women with aggressive NHL. For some women, early delivery when feasible may minimize or avoid exposure to chemotherapy or radiation therapy. Treatment may be delayed for those women with an indolent NHL.

References:

  1. Ward FT, Weiss RB: Lymphoma and pregnancy. Seminars in Oncology 16(5): 397-409, 1989.
  2. Nicklas AH, Baker ME: Imaging strategies in the pregnant cancer patient. Seminars in Oncology 27(6): 623-632, 2000.
  3. Steiner-Salz D, Yahalom J, Samuelov A, et al.: Non-Hodgkin's lymphoma associated with pregnancy: a report of six cases, with a review of the literature. Cancer 56(8): 2087-2091, 1985.
  4. Spitzer M, Citron M, Ilardi CF, et al.: Non-Hodgkin's lymphoma during pregnancy. Gynecologic Oncology 43(3): 309-312, 1991.
  5. Gelb AB, van de Rijn M, Warnke RA, et al.: Pregnancy-associated lymphomas: a clinicopathologic study. Cancer 78(2): 304-310, 1996.
  6. Aviles A, Diaz-Maqueo JC, Torras V, et al.: Non-Hodgkin's lymphomas and pregnancy: presentation of 16 cases. Gynecologic Oncology 37(3): 335-337, 1990.
  7. Moore DT, Taslimi MM: Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy. Journal of the Tennessee Medical Association 84(9): 435-436, 1991.
  8. Nantel S, Parboosingh J, Poon MC: Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy. Medical and Pediatric Oncology 18(2): 143-145, 1990.
Date Last Modified: 03/2002


This information from PDQ is reviewed regularly by members of the PDQ Editorial Boards. If you have specific comments on the content of this information, direct them to: PDQ Editorial Board, CIPS/NCI, 6116 Executive Boulevard, Suite 3002B, MSC-8321, 20892-8321, fax: 301-480-8105. * * The PDQ database also contains listings of clinical trial protocols and directories of organizations and physicians who treat cancer patients, but this information is not available through CancerMail. For more information on accessing PDQ, consult the CancerMail Contents List.
Patients' PDQ


MEDEVENT Congress Server Browse and Submit Oncology Conferences

Sponsors:

  <A HREF ="deutsch/CancernetDSL.ram">Play clip using the stand-alone RealPlayer!</A><A HREF ="http://www.real.com/products/player/d1.html">Click here to download the latest RealPlayer!</A>
small video clip about our work (200 Kbit/s)



Back to the Cancernet contents overview
Questions? Mail them to us!

"This This site complies with the HONcode standard for trustworthy health information:
verify here.

We subscribe to the HON-Code principles of the Health On the Net Foundation We subscribe to the HONcode principles
of the Health On the Net Foundation


Dr. G. Quade
This page was last modified on Sunday, 02-Nov-2003 15:52:16 CET
Impressum